GLP Watchdog

Fridays vs SkinnyRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. Fridays has none. On brand-name tirzepatide pen, SkinnyRx costs $5,136 less a year at standing rates: $1,400 a month against $1,828 a month at Fridays. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / SkinnyRx

Fridays logo

Fridays

5.8/10

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$248/moBrand-name semaglutide pill
States
No state list published
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit SkinnyRx

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (Fridays 5.8, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. Fridays has none.

  2. 02

    Fridays names four pharmacies. SkinnyRx names no compounding pharmacy in our record.

  3. 03

    On brand-name tirzepatide pen, SkinnyRx costs $5,136 less a year at standing rates: $1,400 a month against $1,828 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only SkinnyRx lists a price for compounded oral semaglutide, compounded oral tirzepatide and brand-name semaglutide pill.

  5. 05

    SkinnyRx lists 47 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

SkinnyRx

Compounded semaglutide injection

$249/mo

$2,988 a year

$99/mo

first month only; not compared

Compounded tirzepatide injection

$359/mo

$4,308 a year

$99/mo

first month only; not compared

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

$1,400/moLower

$16,800 a year

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

$1,400/moLower

$16,800 a year

Compounded oral semaglutide
Not sold or not priced

$149/mo

first month only; not compared

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods

Read off each seller’s own pages. Fridays: October 30, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • No FDA warning letter on record
  • Names its compounding pharmacy
  • Publishes no state list
Visit Fridays

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • $1,176 a year less on brand-name semaglutide pen
  • $5,136 a year less on brand-name tirzepatide pen
  • Sells compounded oral semaglutide and compounded oral tirzepatide, which Fridays does not price
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

Fridays 5.8 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.5A
vs
B
2.0

Accessibility10%

5.0A
vs
B
9.5

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs SkinnyRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. Fridays has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. SkinnyRx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
SkinnyRx, by $1,176 a year at standing rates. Fridays: $1,498 a month, about $17,976 a year. SkinnyRx: $1,400 a month, about $16,800 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (Fridays 5.8, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks